Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing lung disease with limited effective therapeutic option. It is characterized by scarring of the lungs over time without a known cause. IPF primarily affects adults over the age of 50 years and is more common in men. The need for treatment of the chronic lung disorder has increased significantly with rising geriatric population. IPF affects around five million people worldwide and its prevalence is increasing over the years. The ... Read more
